A researcher is examining the distribution of an ion channel protein in the kidney. She incubates slices of kidney tissue in a dilute solution of a specific antibody directed against the protein, then uses the immunoperoxidase method to localize the ion channel proteins. She notes the presence of brown pigment in a population of epithelial cells, which on closer examination, have a brush border. The researcher concludes that the protein is probably present in cells of the A. collecting duct B. deep portion of loop of Henle C. distal convoluted tubule D. glomerulus E. proximal convoluted tubule

A researcher is examining the distribution of an ion channel protein in the kidney. She incubates slices of kidney tissue in a dilute solution of a specific antibody directed against the protein, then uses the immunoperoxidase method to localize the ion channel proteins. She notes the presence of brown pigment in a population of epithelial cells, which on closer examination, have a brush border. The researcher concludes that the protein is probably present in cells of the A. collecting duct B. deep portion of loop of Henle C. distal convoluted tubule D. glomerulus E. proximal convoluted tubule

Human Anatomy & Physiology (11th Edition)

11th Edition

ISBN:9780134580999

Author:Elaine N. Marieb, Katja N. Hoehn

Publisher:Elaine N. Marieb, Katja N. Hoehn

Chapter1: The Human Body: An Orientation

Section: Chapter Questions

Problem 1RQ: The correct sequence of levels forming the structural hierarchy is A. (a) organ, organ system,...

See similar textbooks

Similar questions

Why is a blocking buffer needed while running the immunoblotting of the PDVF membrane, furthermore why is skim mil powder often used in the buffers?
How different are theactions of antibodies againstbacteria and against virus?Why is the cellular immuneresponse activated in case ofchronic viral infection?
Can S-layer proteins be detected by immunolabelling when a capsule is present? How do you know? I need help finding the answer in the article and explain in short answer based of the answer in the article
What component must have been present in the positive control solution (antigen, anti-HIV IgG antibodies, or secondary antibody)? Explain how you know this is true.
Can S-layer proteins be detected by immunolabelling when a capsule is present? How do you know? I need help finding the answer in the article and explain in short answer link to article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC106848/
In an immunoblot the primary antibody recognizes: the secondary antibody nitrocellulose BCIP/NBT the protein of interest
Can a mouse infected with Bacillus anthracis generate antibodies against the S-layer? How do you know? I need help finding the answer in the article and explain in short answer link to article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC106848/
. Antibodies of the IgA class are probably more prevalent thanthose of the IgG class. Explain this and define the benefitsthis may have for the host.
In (b), why would it be more efficient to use labeled anti-human IgG rather than label the patient’s antibodies?
How we can Treatment Severe Combined Immunodeficiency (SCID) by using gene therapy? Please answer at your own words,please..
Explain why a tuberculin skin test on an AIDS (acquired immunodeficiencysyndrome) patient with tuberculosis may show a negative result.
Describe the following antigen antibody reactions in serology: Mechanism Function in serology Example of method a) Precipitation b) Agglutination c) Neutralizing d) Complement fixation